Furthermore, EpCAM has a direct effect on tumor cell proliferation by upregulation of c-myc and cyclin A/E[32] and loss of E-cadherin expression is observed in undifferentiated-type gastric carcinomas upon mucosal spread and deep invasion beyond the submucosa[31]. This evidence concerns the gene CDH1 and neoplasm.